Heart Care Info - Heart Disease Prevention & Treatment

... doxorubicin and prednisone (R‐COMP‐14) in elderly patients with poor‐risk diffuse large B‐cell lymphoma and moderate to high 'life threat'impact cardiopathy

G Corazzelli, F Frigeri, M Arcamone... - British journal of ..., 2011 - Wiley Online Library Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat'impact cardiopathy-Corazzelli-2011-British ...

Batist, G., Ramakrishnan, G., Rao, C.S., Chandrasekharan, A., Gutheil, J., Guthrie, T., Shah, P., Khojasteh, A., Nair, M.K., Hoelzer, K., Tkaczuk, K., Park, Y.C. & Lee, L.W. (2001) Reduced cardiotoxicity and preserved antitumor efficacy of liposome encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. Journal of Clinical Oncology, 19, 1444 1454.

Cardinale, D., Colombo, A., Sandri, M.T., Lamantia, G., Colombo, N., Civelli, M., Martinelli, G., Veglia, F., Fiorentini, C. & Cipolla, C.M. (2006) Prevention of high dose chemotherapy induced cardiotoxicity in high risk patients by angiotensin converting enzyme inhibition. Circulation, 114, 2474 2481.

Cheitlin, M.D., Armstrong, W.F., Aurigemma, G.P., Beller, G.A., Bierman, F.Z., Davis, J.L., Douglas, P.S., Faxon, D.P., Gillam, L.D., Kimball, T.R., Kussmaul, W.G., Pearlman, A.S., Philbrick, J.T., Rakowski, H., Thys, D.M., Antman, E.M., Smith, S.C. Jr, Alpert, J.S., Gregoratos, G., Anderson, J.L., Hiratzka, L.F., Hunt, S.A., Fuster, V., Jacobs, A.K., Gibbons, R.J. & Russell, R.O. (2003) ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation, 108, 1146 1162.

Cheson, B.D., Pfistner, B., Juweid, M.E., Gascoyne, R.D., Specht, L., Horning, S.J., Coiffier, B., Fisher, R.I., Hagenbeek, A., Zucca, E., Rosen, S.T., Stroobants, S., Lister, T.A., Hoppe, R.T., Dreyling, M., Tobinai, K., Vose, J.M., Connors, J.M., Federico, M. & Diehl, V. (2007) Revised response criteria for malignant lymphoma. Journal of Clinical Oncology, 25, 579 586.

Corazzelli, G., Capobianco, G., Arcamone, M., Ballerini, P.F., Iannitto, E., Russo, F., Frigeri, F., Becchimanzi, C., Marcacci, G., De Chiara, A. & Pinto, A. (2009) Long term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant ineligible patients with refractory/relapsing B cell lymphoma. Cancer Chemotherapy and Pharmacology, 64, 907 916.

Cunningham, D., Smith, P., Mouncey, P., Qian, W., Pocock, C., Ardeshna, K.M., Radford, J., Mc Millan, A. & Linch, D. (2009) A phase III trial comparing R CHOP 14 and R CHOP 21 for the treatment of patients with newly diagnosed diffuse large B cell non Hodgkin s lymphoma. Journal of Clinical Oncology, 27 (Suppl; abstract 8506).

Delarue, R., Tilly, H., Salles, G., Gisselbrecht, C., Mounier, N., Fournier, M., Molnar, M., Bonmati, C., Ghesquieres, H., Blanc, M., Germain, D., Girard, L., Haioun, C. & Bosly, A. (2009) R CHOP14 compared to R CHOP21 in elderly patients with diffuse large B cell lymphoma: results of the interim analysis of the LNH03 6B GELA study. Blood, 114 (abstract 406).

Feugier, P., Van Hoof, A., Sebban, C., Solal Celigny, P., Bouabdallah, R., Ferme, C., Christian, B., Lepage, E., Tilly, H., Morschhauser, F., Gaulard, P., Salles, G., Bosly, A., Gisselbrecht, C., Reyes, F. & Coiffier, B. (2005) Long term results of the R CHOP study in the treatment of elderly patients with diffuse large B cell lymphoma: a study by the Groupe d Etude des Lymphomes de l Adulte. Journal of Clinical Oncology, 23, 4117 4126.

Gisselbrecht, C., Glass, B., Mounier, N., Gill, D., Linch, D., Trneny, M., Bosly, A., Shpilberg, O., Ketterer, N., Moskowitz, C. & Schmitz, N. (2009) R ICE versus R DHAP in relapsed patients with CD20 diffuse large B cell lymphoma followed by autologous stem cell transplantation [abstract]. Journal of Clinical Oncology (ASCO Meeting Abstracts), 27, 8509.